Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations
Matthias Scheffler, Alessandra Holzem, Anna Kron, Lucia Nogová, Michaela A. Ihle, Cornelia von Levetzow, Jana Fassunke, C. Wömpner, Elisabeth Bitter, Sophia Koleczko, Diana S.Y. Abdulla, Sebastian Michels, Rieke Fischer, Richard Riedel, Jan-Philipp Weber, Theresa Westphal, Ulrich Gerigk, Jens Kern, Britta Kaminsky, Winfried Randerath, K Kambartel, Sabine Merkelbach‐Bruse, Reinhard Büttner, Jürgen Wolf
Topics & Concepts
MedicineMutationLung cancerCancer researchAdenocarcinomaV600EROS1OncologyCancerInternal medicineGeneGeneticsBiologyMelanoma and MAPK PathwaysLung Cancer Treatments and MutationsCancer Mechanisms and Therapy